SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Optimer Pharmaceuticals, Inc. Initiates Phase 3b Clinical Trial of DIFICID® for the Prevention of Clostridium difficile-Associated Diarrhea in Bone Marrow Transplant Patients